Evidence map›Paper›PMID 33770146›Full record

ArticlePLoS pathogens2021

Deconvolution of intergenic polymorphisms determining high expression of Factor H binding protein in meningococcus and their association with invasive disease.

Marco Spinsanti, Tarcisio Brignoli, Margherita Bodini, Lucia Eleonora Fontana, Matteo De Chiara, Alessia Biolchi, Alessandro Muzzi, Vincenzo Scarlato, Isabel Delany

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Marco SpinsantiGSK, Siena, Italy.ORCID 0000-0002-5098-3901
Tarcisio BrignoliGSK, Siena, Italy.ORCID 0000-0003-4601-4080
Margherita BodiniGSK, Siena, Italy.ORCID 0000-0002-7054-8712
Lucia Eleonora FontanaGSK, Siena, Italy.ORCID 0000-0002-1871-1084
Matteo De ChiaraGSK, Siena, Italy.ORCID 0000-0003-1014-350X
Alessia BiolchiGSK, Siena, Italy.
Alessandro MuzziGSK, Siena, Italy.ORCID 0000-0002-8635-6424
Vincenzo ScarlatoDepartment of Pharmacy and Biotechnology (FaBiT), University of Bologna, Bologna, Italy.ORCID 0000-0003-4227-677X
Isabel DelanyGSK, Siena, Italy.
University of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neisseria meningitidis is a strictly human pathogen and is the major cause of septicemia and meningitis worldwide. Factor H binding protein (fHbp) is a meningococcal surface-exposed lipoprotein that binds the human Complement factor H allowing the bacterium to evade the host innate immune response. FHbp is also a key antigen in two vaccines against N. meningitidis serogroup B. Although the fHbp gene is present in most circulating meningococcal strains, level of fHbp expression varies among isolates and has been correlated to differences in promoter sequences upstream of the gene. Here we elucidated the sequence determinants that control fHbp expression in globally circulating strains. We analyzed the upstream fHbp intergenic region (fIR) of more than 5800 strains representative of the UK circulating isolates and we identified eleven fIR sequence alleles which represent 88% of meningococcal strains. By engineering isogenic recombinant strains where fHbp expression was under the control of each of the eleven fIR alleles, we confirmed that the fIR sequence determines a specific and distinct level of expression. Moreover, we identified the molecular basis for variation in expression through polymorphisms within key regulatory regions that are known to affect fHbp expression. We experimentally established three expression groups, high-medium-low, that correlated directly with the susceptibility to killing mediated by anti-fHbp antibodies and the ability of the meningococcal strain to survive within human serum. By using this sequence classification and information about the variant, we predicted fHbp expression in the panel of UK strains and we observed that strains with higher expressing fIR alleles are more likely associated with invasive disease. Overall, our findings can contribute to understand and predict vaccine coverage mediated by fHbp as well as to shed light on the role of this virulence factor in determining an invasive phenotype.

Indexed as

Antigens, BacterialBacterial ProteinsHumansMeningococcal InfectionsMeningococcal VaccinesNeisseria meningitidisPolymorphism, GeneticAntigens, BacterialBacterial Proteinsfactor H-binding protein, Neisseria meningitidisMeningococcal Vaccines

Identifiers

PMID33770146
PMCPMC8026042
OpenAlexW3137967815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.